Biomarkers in bladder cancer
- 11 February 2010
- journal article
- review article
- Published by Wiley in BJU International
- Vol. 105 (5) , 608-613
Abstract
Detailed molecular insights into bladder cancer biology might allow more detailed prognostication and optimization of treatment with the objective of improving patient outcome and quality of life. However, in bladder cancer research the search for biomarkers has been called into question and has even obtained notoriety. It is unlikely that any single marker will be able to improve prognostication for patients with bladder cancer above and beyond grade and stage, but a combination of multiple independent markers might more precisely predict the outcome. From a previous review, we identified seven biomarkers to study within the setting of the Bladder Cancer Prognosis Programme (BCPP), a 5‐year multicentre programme of research based at the University of Birmingham and funded by Cancer Research UK, investigating their effectiveness in predicting recurrence and progression. As part of the ongoing quality‐assurance process for BCPP we present an updated review of our selected biomarkers, as well as highlighting other recent important developments in bladder cancer research.Keywords
This publication has 75 references indexed in Scilit:
- Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyondBritish Journal of Cancer, 2009
- Economic aspects of bladder cancer: what are the benefits and costs?World Journal of Urology, 2009
- Does the biomarker search paradigm need re-booting?BMC Urology, 2009
- Recurrent and multiple bladder tumors show conserved expression profilesBMC Cancer, 2008
- Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategyLaboratory Investigation, 2008
- FGFR3 protein expression and its relationship to mutation status and prognostic variables in bladder cancerThe Journal of Pathology, 2007
- Targeting vasculature in urologic tumors: Mechanistic and therapeutic significanceJournal of Cellular Biochemistry, 2007
- Heparin‐binding epidermal growth factor‐like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcomeCancer, 2007
- The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transitional cell carcinoma of the urinary bladderBritish Journal of Cancer, 2006
- The Hallmarks of CancerCell, 2000